Monday, April 25, 2016

BRIEF-Knight Therapeutics says received Notice Of Deficiency for its ATryn new drug submission

* Has received a notice of deficiency for its ATryn new drug

submission

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)